Inventor
Yuki Taga
Inventor
Tokyo, JP
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
C12NMicroorganisms or enzymes19%
A61KPreparations for medical, dental or toiletry purposes14%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%
C12YEnzymes5%
PatentTitleYear
10,925,962Polymeric IgA-type recombinant antibody and use thereof202110,442,843Method for producing protein20199,884,897'Method for producing protein'20189,486,491'Collagen peptide composition production method, DPP-4 inhibitor, and antihyperglycemic agent'20169,340,579'DPP-4 inhibitor'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2021Patents assigned to NIPPI INCORPORATED (4)· patent assignee history
2016Patents assigned to NIPPI INC (1)· patent assignee history
2016–2021Based in Tokyo, JP· patent location history
2021Patents assigned to JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NIPPI INCORPORATED | 4 | 2016–2021 |
| JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES | 1 | 2021 |
| NIPPI INC | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tokyo, JP | 5 | 2016–2021 |